How can public and private healthcare bodies work together to increase innovation in oncology drug development?
In this episode of the Why podcast, Sukhun Kang, an award-winning PhD student at London Business School, answers this question as he discusses his research into oncology drug development. A research project sponsored by the Wheeler Institute for Business and Development He explains how innovation in this field could be transformed and enhanced by greater collaboration – particularly between public bodies and the private sector.
Sukhun Kang is a PhD student in Strategy and Entrepreneurship at London Business School. He’s recently been awarded the school’s prestigious Sir James Ball PhD Prize.
Zoë Stumpf is Head of Thought Leadership & Research Amplification at London Business School.
Discover fresh perspectives and research insights from LBS
Sign up to receive our latest news and business thinking direct to your inbox
London Business School takes your privacy seriously. We may process your personal information for carefully considered, specific purposes which enable us to enhance our services and benefit our customers. Please note that by subscribing now you may from time to time receive other emails from LBS about events or other activities that we think might interest you. View our Privacy Policy to learn more.
Thank you. You're almost ready to start enjoying Think. To verify your email and confirm your subscription please click on the link that we've sent to your email address.
